Training Your Brain With Poker
According to some historians, the game of poker can be traced back to 10th-century China. Others believe it derives from...
Day: May 13, 2022
cbdMD Reports Sequential Increase in Net Sales
Positive Near-Term Sales Trend Expected, Significant Operational Adjustments ImplementedCharlotte, North Carolina--(Newsfile Corp. - May 13, 2022) - cbdMD, Inc. (NYSE...
Scryb Announces Software Evaluation of Cybeats Cybersecurity Platform with Global Safety Certification Company
Toronto, Ontario--(Newsfile Corp. - May 13, 2022) - Scryb Inc. (CSE: SCYB) (OTCQB: SCYRF) (FSE: EIY) ("Scryb'' or the "Company"), is pleased...
Scientific Industries to Report Third Quarter Fiscal Year 2022 Financial Results on May 16, 2022
Investor Call to be held May 18th at 4:30 p.m. Eastern TimeBOHEMIA, NY / ACCESSWIRE / May 13, 2022 /...
AESARA, Inc. to Present New Health Economics and Outcomes Research (HEOR) Data at the 2022 Annual Meeting of the International Society of Pharmacoeconomics and Outcomes Research (ISPOR)
CHAPEL HILL, N.C., TORONTO & LONDON--(BUSINESS WIRE)--#HEOR--AESARA (www.aesara.com) is pleased to announce their attendance and poster presentations this ISPOR 2022...
Ontada Research Highlights Power of Real-World Oncology Data at ISPOR 2022
Studies Show the Ability of Real-World Oncology Evidence to Generate Insights into Treatment Effectiveness and Patient Outcomes IRVING, Texas--(BUSINESS WIRE)--Ontada®,...
Love Hemp Group PLC Announces Update to Announcement of 9 May 2022
LONDON, UK / ACCESSWIRE / May 13, 2022 / Love Hemp Group PLC (AQSE:LIFE)(OTCQB:WRHLF), the brand-led consumer goods company focused...
Spectral to Present at Microcap Rodeo’s Spring into Action Best Ideas Virtual Conference on May 16th
TORONTO, ON / ACCESSWIRE / May 13, 2022 / Spectral Medical Inc. ("Spectral" or the "Company") (TSX:EDT), a late stage...
Adaptive Ad Systems Reports Record Results for Q1 2022
Increase of 19% in Revenue and 83% Net Profit Year over Year Proprietary Technology provides Market AdvantageVANCOUVER, WA / ACCESSWIRE...
Diamond Expands Product Offering With Launch of THC Cartridges
Delta 8 carts, Delta 10 carts, HHC carts and more offer exciting new strains and flavorsFT LAUDERDALE, FL / ACCESSWIRE...
StageZero to Issue Q1 2022 Financial Results and Hold Conference Call on Tuesday May 17
TORONTO, ON / ACCESSWIRE / May 13, 2022 / StageZero Life Sciences ("StageZero" or the "Company") (TSX:SZLS) today announced that...
TRIOSE’s Natalie Jones Receives Supply & Demand Chain Executive’s 2022 Pros to Know Award
WYOMISSING, Pa., May 13, 2022 (GLOBE NEWSWIRE) -- TRIOSE Inc., the leading provider of intelligent healthcare supply chain solutions, is...
Palisade Bio Reports First Quarter 2022 Financial Results and Provides Corporate Update
Phase 3 study of LB1148 in lead indication for postoperative return of bowel function on track to commence Q2 2022...
Ceapro Inc. Present PGX Enabling Technology Case Study at the 13th International Symposium on Supercritical Fluids
PGX Technology continues to demonstrate ability to generate novel bioactive delivery systems for nutraceuticals, drug delivery and wound healingEDMONTON, Alberta,...
Sienna Announces May Dividend
MARKHAM, Ontario, May 13, 2022 (GLOBE NEWSWIRE) -- Sienna Senior Living Inc. (“Sienna” or the “Company”) (TSX: SIA) today announced...
ABVC BioPharma Engages the FreeMind Group to Support Grant Funding
FREMONT, CA, May 13, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – ABVC BioPharma, Inc. (NASDAQ: ABVC), a clinical stage biopharmaceutical...
Ozop Energy Solutions, Inc. Attending Agent Summit 2022 Conference beginning May 15 in Las Vegas
Ozop Plus is Reinsurance Symposium Premier Sponsor Florida, NY, May 13, 2022 (GLOBE NEWSWIRE) -- Ozop Energy Solutions. Inc. (OZSC),...
Checkpoint Therapeutics Receives Pediatric Investigational Plan Waivers for Cosibelimab from the European Medicines Agency and U.K. Medicines & Healthcare Products Regulatory Agency
Waivers remove requirement to conduct pediatric clinical studies to support cosibelimab marketing authorization applications in EuropeWALTHAM, Mass., May 13, 2022...
POINT Biopharma Reports First Quarter 2022 Financial Results and Provides Business Update
POINT's manufacturing facility initiated supply for the Phase 3 SPLASH trial. Randomization of patients for the SPLASH trial expanded to...
Vallon Pharmaceuticals Announces $3.9 Million Registered Direct Offering
PHILADELPHIA, PA, May 13, 2022 (GLOBE NEWSWIRE) -- Vallon Pharmaceuticals, Inc. (NASDAQ: VLON), (“Vallon” or the “Company”), a clinical-stage biopharmaceutical...